ClinicalTrials.Veeva

Menu

Neuroinflammatory Response and Headache Control in Patients After Subarachnoid Hemorrhage (HASH4-CSF)

M

MaineHealth

Status

Active, not recruiting

Conditions

Subarachnoid Hemorrhage
Subarachnoid Hemorrhage, Aneurysmal
Headache

Study type

Observational

Funder types

Other

Identifiers

NCT03604276
1100316-599

Details and patient eligibility

About

The purpose of this study is to determine the relationship between the Neuroinflammatory response and headache pain after subarachnoid hemorrhage.

Full description

Persistent headache is a significant medical issue that affects 20% of patients who survive an aneurysmal subarachnoid hemorrhage (SAH). This headache may last years, severely affecting quality of life. Laboratory evidence suggests that the persistent headache may be a result of a maladaptive neuroinflammatory response to the hemorrhage injury that is more vigorous than necessary. The goal of this study is to measure key immunomodulators in the blood and the cerebrospinal fluid of these patients in order to determine the magnitude and dynamics of their neuroinflammatory response. In addition, the investigators will collect and analyze observational data about the success of medications to treat headache, with a specific focus on the anti-inflammatory agent dexamethasone, in managing acute headache pain and preventing the development of persistent headaches in patients after SAH.

Enrollment

60 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Non-traumatic subarachnoid hemorrhage
  • Age > 18 years
  • Treated with external ventricular drainage

Exclusion criteria

  • Pregnancy or lactation
  • Age < 18 years
  • Traumatic SAH

Trial contacts and locations

1

Loading...

Central trial contact

Ashley Eldridge, BSN, RN; Christine Lord, BSN, RN-BC

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems